Statistics for the Plotted Points |
11-KETOTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 108% | 21% | 108% | 22% |
>= Reporting Level | 4 | 63% | 4% | 65% | 4% |
Total | 8 | 86% | 28% | 75% | 32% |
Miscellaneous Statistics for the Samples |
11-KETOTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 8 | 62% | Spiked |
Estimated Values | 1 | 8% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 23% | Spiked |
Spiked | 13 | . | |
False Negatives | 2 | 15% | 2 out of 13 |
Not Spiked | 81 | . | |
False Positives | 1 | 1% | 1 out of 80 |
Statistics for the Plotted Points |
17-ALPHA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 42 | 85% | 15% | 86% | 13% |
Total | 42 | 85% | 15% | 86% | 13% |
Miscellaneous Statistics for the Samples |
17-ALPHA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 42 | 98% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 1 | 2% | 1 out of 43 |
Not Spiked | 51 | . | |
False Positives | 0 | 0% | 0 out of 51 |
Statistics for the Plotted Points |
17-ALPHA-ETHYNYLESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 81% | 16% | 81% | 13% |
Total | 40 | 81% | 16% | 81% | 13% |
Miscellaneous Statistics for the Samples |
17-ALPHA-ETHYNYLESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 93% | Spiked |
Estimated Values | 4 | 9% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 43 | . | |
False Negatives | 2 | 5% | 2 out of 43 |
Not Spiked | 51 | . | |
False Positives | 0 | 0% | 0 out of 51 |
Statistics for the Plotted Points |
17-BETA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 43 | 87% | 17% | 87% | 15% |
Total | 43 | 87% | 17% | 87% | 15% |
Miscellaneous Statistics for the Samples |
17-BETA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 100% | Spiked |
Estimated Values | 2 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 0 | 0% | 0 out of 43 |
Not Spiked | 51 | . | |
False Positives | 1 | 2% | 1 out of 51 |
Statistics for the Plotted Points |
NORETHINDRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 105% | . | 105% | 0% |
>= Reporting Level | 37 | 88% | 20% | 87% | 18% |
Total | 38 | 88% | 20% | 87% | 19% |
Miscellaneous Statistics for the Samples |
NORETHINDRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 38 | 88% | Spiked |
Estimated Values | 7 | 16% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 5 | 12% | 5 out of 43 |
Not Spiked | 51 | . | |
False Positives | 0 | 0% | 0 out of 50 |
Statistics for the Plotted Points |
3-BETA-COPROSTANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 36 | 97% | 33% | 91% | 13% |
Total | 36 | 97% | 33% | 91% | 13% |
Miscellaneous Statistics for the Samples |
3-BETA-COPROSTANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 100% | Spiked |
Estimated Values | 3 | 8% | Spiked |
Deleted Values | 7 | 8% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 39 | . | |
False Negatives | 0 | 0% | 0 out of 36 |
Not Spiked | 44 | . | |
False Positives | 6 | 15% | 6 out of 40 |
Statistics for the Plotted Points |
4-ANDROSTENE-3,17-DIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 13 | 91% | 16% | 87% | 19% |
Total | 13 | 91% | 16% | 87% | 19% |
Miscellaneous Statistics for the Samples |
4-ANDROSTENE-3,17-DIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 13 | 93% | Spiked |
Estimated Values | 1 | 7% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 7% | Spiked |
Spiked | 14 | . | |
False Negatives | 0 | 0% | 0 out of 14 |
Not Spiked | 80 | . | |
False Positives | 2 | 3% | 2 out of 79 |
Statistics for the Plotted Points |
CHOLESTEROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 36 | 107% | 37% | 99% | 16% |
Total | 36 | 107% | 37% | 99% | 16% |
Miscellaneous Statistics for the Samples |
CHOLESTEROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 100% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 7 | 8% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 39 | . | |
False Negatives | 0 | 0% | 0 out of 36 |
Not Spiked | 44 | . | |
False Positives | 6 | 15% | 6 out of 40 |
Statistics for the Plotted Points |
CIS-ANDROSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 89% | 25% | 83% | 16% |
Total | 34 | 89% | 25% | 83% | 16% |
Miscellaneous Statistics for the Samples |
CIS-ANDROSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 94% | Spiked |
Estimated Values | 7 | 19% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 36 | . | |
False Negatives | 1 | 3% | 1 out of 36 |
Not Spiked | 58 | . | |
False Positives | 0 | 0% | 0 out of 57 |
Statistics for the Plotted Points |
TRANS-DIETHYLSTILBESTROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 80% | . | 80% | 0% |
>= Reporting Level | 42 | 73% | 19% | 69% | 21% |
Total | 43 | 73% | 19% | 69% | 21% |
Miscellaneous Statistics for the Samples |
TRANS-DIETHYLSTILBESTROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 88% | Spiked |
Estimated Values | 3 | 6% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 50 | . | |
False Negatives | 6 | 12% | 6 out of 49 |
Not Spiked | 44 | . | |
False Positives | 0 | 0% | 0 out of 44 |
Statistics for the Plotted Points |
EPITESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 58% | 18% | 52% | 5% |
>= Reporting Level | 25 | 92% | 26% | 90% | 18% |
Total | 30 | 86% | 27% | 85% | 19% |
Miscellaneous Statistics for the Samples |
EPITESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 100% | Spiked |
Estimated Values | 8 | 27% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 0 | 0% | 0 out of 30 |
Not Spiked | 63 | . | |
False Positives | 2 | 3% | 2 out of 63 |
Statistics for the Plotted Points |
EQUILENIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 33 | 67% | 28% | 71% | 30% |
Total | 33 | 67% | 28% | 71% | 30% |
Miscellaneous Statistics for the Samples |
EQUILENIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 89% | Spiked |
Estimated Values | 10 | 27% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 37 | . | |
False Negatives | 3 | 8% | 3 out of 37 |
Not Spiked | 57 | . | |
False Positives | 13 | 23% | 13 out of 57 |
Statistics for the Plotted Points |
EQUILIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 75% | 25% | 64% | 34% |
>= Reporting Level | 34 | 68% | 32% | 70% | 21% |
Total | 37 | 68% | 31% | 70% | 19% |
Miscellaneous Statistics for the Samples |
EQUILIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 37 | 76% | Spiked |
Estimated Values | 37 | 76% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 51 | . | |
False Negatives | 11 | 22% | 11 out of 49 |
Not Spiked | 43 | . | |
False Positives | 0 | 0% | 0 out of 43 |
Statistics for the Plotted Points |
ESTRIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 9 | 96% | 41% | 84% | 9% |
>= Reporting Level | 39 | 80% | 23% | 78% | 19% |
Total | 48 | 83% | 28% | 79% | 18% |
Miscellaneous Statistics for the Samples |
ESTRIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 48 | 86% | Spiked |
Estimated Values | 11 | 20% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 5% | Spiked |
Spiked | 57 | . | |
False Negatives | 5 | 9% | 5 out of 56 |
Not Spiked | 37 | . | |
False Positives | 3 | 8% | 3 out of 37 |
Statistics for the Plotted Points |
ESTRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 47 | 101% | 26% | 99% | 25% |
Total | 47 | 101% | 26% | 99% | 25% |
Miscellaneous Statistics for the Samples |
ESTRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 47 | 94% | Spiked |
Estimated Values | 5 | 10% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 2 | 4% | Spiked |
Spiked | 50 | . | |
False Negatives | 1 | 2% | 1 out of 50 |
Not Spiked | 44 | . | |
False Positives | 0 | 0% | 0 out of 43 |
Statistics for the Plotted Points |
MESTRANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 143% | . | 143% | 0% |
>= Reporting Level | 44 | 88% | 48% | 70% | 49% |
Total | 45 | 90% | 48% | 70% | 57% |
Miscellaneous Statistics for the Samples |
MESTRANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 90% | Spiked |
Estimated Values | 3 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 4% | Spiked |
Spiked | 50 | . | |
False Negatives | 3 | 6% | 3 out of 50 |
Not Spiked | 44 | . | |
False Positives | 0 | 0% | 0 out of 44 |
Statistics for the Plotted Points |
PROGESTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 15 | 84% | 42% | 87% | 33% |
>= Reporting Level | 25 | 56% | 29% | 50% | 11% |
Total | 40 | 66% | 37% | 52% | 29% |
Miscellaneous Statistics for the Samples |
PROGESTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 78% | Spiked |
Estimated Values | 40 | 78% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 9 | 18% | Spiked |
Spiked | 51 | . | |
False Negatives | 2 | 4% | 2 out of 51 |
Not Spiked | 43 | . | |
False Positives | 0 | 0% | 0 out of 43 |
Statistics for the Plotted Points |
DIHYDROTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 11 | 142% | 54% | 156% | 85% |
>= Reporting Level | 12 | 70% | 39% | 65% | 8% |
Total | 23 | 104% | 58% | 79% | 72% |
Miscellaneous Statistics for the Samples |
DIHYDROTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 23 | 96% | Spiked |
Estimated Values | 8 | 33% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 4% | Spiked |
Spiked | 24 | . | |
False Negatives | 0 | 0% | 0 out of 24 |
Not Spiked | 70 | . | |
False Positives | 0 | 0% | 0 out of 70 |
Statistics for the Plotted Points |
TESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 19 | 95% | 17% | 92% | 15% |
Total | 19 | 95% | 17% | 92% | 15% |
Miscellaneous Statistics for the Samples |
TESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 19 | 100% | Spiked |
Estimated Values | 2 | 11% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 19 | . | |
False Negatives | 0 | 0% | 0 out of 19 |
Not Spiked | 75 | . | |
False Positives | 0 | 0% | 0 out of 74 |